Management of fetal growth restriction: an evidence-based approach.
This review provides an evidence-based approach to the management of fetal growth restriction (FGR). The management consists of the following components: appropriate fetal surveillance, timely intervention, and selective etiological management. Umbilical arterial (UA) Doppler sonography is the primary test. Supplementary tests include nonstress test (NST), amniotic fluid assessment, biophysical profile (BPP), and selective venous Doppler sonography. Ominous signs include UA absent or reverse end-diastolic flow, non-assuring NST, low BPP, and abnormal fetal venous flow patterns. An evidence-based clinical management guideline is included and individualization of care is recommended.
Maulik
Dev
D
Department of Obstetrics and Gynecology, Winthrop University Hospital, Mineola, New York 11501, USA. wirving@winthrop.org
D000653:Amniotic Fluid; D019317:Evidence-Based Medicine; D005260:Female; D005317:Fetal Growth Retardation / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011256:Pregnancy Outcome; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D018615:Ultrasonography, Doppler, Color; D016216:Ultrasonography, Prenatal / Q000379:methods